ProfNicolas Hart

Professor Hart has received >$26 million AUD research income as chief investigator to undertake research improving outcomes for people with advanced cancer. This includes a prestigious fellowships from the National Health and Medical Research Council (2023-2027) to improve outcomes for people with bone metastases; and the Cancer Council of Western Australia (2018-2020) to investigate approaches to delay disease progression and extend overall survival in advanced cancer patients through exercise medicine; chief investigator (CIH) for 1 NHMRC project grant, CID and CIE for 2 MRFF grants; and chief investigator (Co-PI) for several national and international multicentre randomised controlled trials (i.e., INTERVAL-GAP4, TrueNTH Australia, and more).


[COMPETITIVE RESEARCH FUNDING - CAT 1]

Maximising the System's Potential to Optimise Living Well with Cancer (MAXIMISE-CRE). NHMRC Centre for Research Excellence, 2027-2032, $3,136,500 AUD

An Equitable Model of Comprehensive Cancer Survivorship Care for Adolescents and Young Adults.  MRFF (Medical Research Future Fund) Survivorship Care Research Prioritisation Grant, 2025-2029, $2,364,222 AUD

Driving Equitable Cancer Outcomes across Australia: Establishing a Nationally Scalable Model to Embed Best Practice Cancer Care into Rural Health Services. MRFF (Medical Research Future Fund) Early-to-Mid Career Researcher Grant, 2024 - 2028, $5,168,291 AUD

The MyWELL Study: Empowering People with Myeloma to not just Live but Live Well. MRFF (Medical Research Future Fund) Consumer-Led Grant, 2024 to 2028, $533,131 AUD

Improving Outcomes for People with Bone Metastases. NHMRC (National Health and Medical Research Council). Investigator Grant. Emerging Leadership Fellow (EL2), 2023 - 2027, $1,576,390 AUD

Rebuilding Bone with Exercise in Multiple Myeloma. WCRF (World Cancer Research Fund). Investigator Initiated Grant, 2023 - 2026, $608,994 AUD

Implementing a Nurse-Enabled, Shared-Care Model to Address Unmet Needs of People with Neuroendocrine Tumours: the AUS-NET Trial. MRFF (Medical Research Future Fund), 2023 - 2026, $2,501,220 AUD.

A hybrid, implementation-effectiveness trial of a shared-care MOdel for proStatE cancer Survivors (The MOSES Trial). MRFF (Medical Research Future Fund), 2022 - 2025, $1,625,287 AUD

Can Exercise Delay Transition to Active Therapy in Men with Low Grade Prostate Cancer? A Multi-Centre Randomised Controlled Trial. NHMRC (National Health and Medical Research Council), 2018 - 2023, $596,084 AUD.

INTense Exercise foR surVivAL among men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a Multicentre, Randomized, Controlled, Phase III Study. Movember Foundation, 2016 - 2023, $635,910 AUD.

Exercise Coordinating Centre for INTERVAL-GAP4: Intense exercise for survival among men with Metastatic Castrate-Resistant Prostate Cancer. Movember Foundation, 2016 - 2024, $548,776 AUD.

An exploratory study to determine if exercise can impact the gut microbiota composition of men receiving androgen suppression therapy for prostate cancer. PCFA (Prostate Cancer Foundation Australia), 2018 - 2023, $98,875 AUD.

Australian Centre for Research into Injury in Sport and its Prevention (ACRISP), Research Centres for Prevention of Injury and Protection of Athlete Health. IOC (International Olympic Committee), 2019 - 2022, $568,107 AUD.

TrueNTH solutions: an integrated multi-component intervention to improve the lives of men with prostate cancer in Australia - Demonstration of the Lifestyle and Exercise Program. Movember Foundation, 2016 - 2020, $303,145 AUD.

Mechanical modulation of bone metastases in advanced breast cancer patients: Can targeted exercise suppress osteolytic tumour progression?. NBCF (National Breast Cancer Foundation), 2016 - 2019, $184,300 AUD.


[COMPETITIVE RESEARCH FUNDING - CAT 2]

Re-designing the head and neck cancer monitoring program: considering patient preferences and acceptability. Tour de Cure SA Discovery Tour Grant, 2022 - 2024, $100,000 AUD.

Procurement of goods and services to undertake a critical analysis and knowledge synthesis in relation to Patient Navigation in the cancer setting. Cancer Australia (Approach To Market). 2022 - 2022, $117,418 AUD.

Using deep machine learning and an artificial intelligence approach to automatically detect clinical pathologies and movement artefact in peripheral quantitative computed tomography (pQCT) scans. CSIRO (Commonwealth Scientific & Industrial Research Organisation), 2022 - 2025, $114,835 AUD.

Lower-body injury risk stratification in female and male recruits through muscle-bone imaging., Department of Jobs, Tourism, Science and Innovation, Defence Science Collaborative Research Grants, 2020 - 2022, $432,075 AUD.

Delivering supervised group exercise to patients with cancer via telehealth: an implementation study. PARF (Princess Alexandra Hospital Research Foundation). 2021 - 2022, $100,000 AUD

The effect of cognitive and exercise training on Brain Atrophy and Cognitive Decline in Breast Cancer Patients Treated with Adjuvant Chemotherapy Agents, Cancer Council of WA Inc, Collaborative Cancer Grant Scheme, 2018 - 2022, $49,966 AUD.

Examining the effect of creatine supplementation in augmenting adaptations to resistance training in prostate cancer patients undergoing androgen deprivation therapy: a randomised, double-blind, placebo controlled trial. , Cancer Council of WA Inc, Collaborative Cancer Grant Scheme, 2019 - 2022, $64,560 AUD.

Exercise medicine for advanced cancer patients: a synergistic and targeted approach to delay disease progression and extend survival., Cancer Council of WA Inc, Fellowship, 2018 - 2020, $601,458 AUD.

Can exercise interfere with sclerotic tumour formation and reduce tumour growth in advanced prostate cancer patients with bone metastasis? – A phase I, randomised clinical trial examining feasibility, safety and efficacy., Cancer Council of WA Inc, Grant - Early Career Investigator, 2016 - 2018, $34,742 AUD.

Mechanical modulation of bone metastases in advanced prostate cancer patients: Can targeted exercise suppress sclerotic tumour progression? – A pilot study., Exercise & Sports Science Australia, Clinical Exercise Physiology Research Grant, 2015 - 2017, $37,200 AUD.


[COMPETITIVE RESEARCH FUNDING - CAT 3]

Determining the optimal exercise prescription (modalities, volume, intensity, frequency, and duration) for improving bone health within a sustainable school-based environment. WABRC (Western Australian Bone Research Collaboration), 2022 to 2025, $90,000 AUD.

Exploring big data and data analytics within an elite Australian Football League team, underpinning the screening, prevention, incidence and rehabilitation of bone stress injuries in professional footballers, Pernix, Scholarships to support Industry Engagement PhD projects, 2019 - 2022, $52,500 AUD.

From Research to Practice: the development, implementation and evaluation of an intervention to integrate exercise into standard of care for people with cancer, Genesis Cancer Care Pty Ltd, Genesis Cancer Care - Grant, 2018 - 2020, $10,000 AUD.

Feasibility and efficacy of dosing exercise medicine immediately before or after chemotherapy infusion, Edith Cowan University, Ipsen Pharmaceuticals, Pty Ltd and ECU Industry Collaboration Grant - 2017 Open Round, 2018 - 2020, $135,247 AUD.

Characterisation of musculoskeletal health, motor development and exercise capacity of children who have completed therapy for acute lymphoblastic leukaemia (ALL)., Edith Cowan University, ECU Early Career Researcher Grant - 2017, 2017 - 2019, $30,000 AUD.

New Independent Researcher Infrastructure Support (NIRIS) Awards, Department of Health WA, New Independent Researcher Infrastructure Support (NIRIS) Awards, 2017 - 2018, $10,000 AUD.

Mechanical Specificity of Weightlifting Movements to Athletic Performance, National Strength and Conditioning Association, Grant, 2010 - 2013, $13,591 AUD.